Related Experiment Videos
Raised epidermal phospholipase A2 activity in rheumatoid arthritis
H G Taylor1, P T Dawes, A Ilchyshyn
1Skin Department, North Staffordshire Hospital Centre, Stoke-on-Trent, UK.
Clinical and Experimental Rheumatology
|May 1, 1991
Summary
Epidermal phospholipase A2 (PLA2) levels are elevated in rheumatoid arthritis (RA) patients compared to healthy individuals. Changes in PLA2 activity over time correlate with RA disease activity.
Area of Science:
- Biochemistry
- Immunology
- Dermatology
Background:
- Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease.
- Phospholipase A2 (PLA2) enzymes play a role in inflammatory processes.
- Elevated PLA2 activity has been implicated in various inflammatory conditions.
Purpose of the Study:
- To investigate epidermal phospholipase A2 (PLA2) levels in patients with rheumatoid arthritis (RA).
- To compare PLA2 activity between RA patients, psoriatic patients, and healthy individuals.
- To explore the relationship between PLA2 activity and rheumatoid disease activity.
Main Methods:
- Cross-sectional and longitudinal studies were conducted.
- Epidermal PLA2 activity was measured.
- Comparison of PLA2 levels across different patient groups and with disease activity measures.
Main Results:
- Epidermal PLA2 activity was significantly higher in RA patients than in normal individuals (p < 0.0001).
- PLA2 activity in RA patients was lower than in psoriatic patients (p < 0.05).
- No correlation was found between PLA2 activity and disease activity in the cross-sectional study.
- A strong correlation was observed between changes in PLA2 activity and changes in disease activity in the longitudinal study.
Conclusions:
- Epidermal PLA2 is elevated in RA patients, suggesting its involvement in the disease.
- While not directly correlating with disease severity at a single point, PLA2 activity dynamics reflect RA progression.
- PLA2 may serve as a potential biomarker for monitoring RA disease activity over time.